The Aerogen^® Solo Is an Alternative to the Small Particle Aerosol Generator (SPAG-2) for Administration of Inhaled Ribavirin

• Main Authors: Ronald H. Dallas (Author), Jason K. Rains (Author), Keith Wilder (Author), William Humphrey (Author), Shane J. Cross (Author), Saad Ghafoor (Author), Jessica N. Brazelton de Cardenas (Author), Randall T. Hayden (Author), Diego R. Hijano (Author)
• Format: Book
• Published: MDPI AG, 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Respiratory syncytial virus (RSV) is associated with adverse outcomes among immunocompromised patients. Inhaled ribavirin has been shown to improve mortality rates. The Small-Particle Aerosol Generator delivery system (SPAG-2) is the only FDA-cleared device to deliver inhaled ribavirin. However, it...